WebMD6 天
FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
Feb. 18, 2025 – The FDA has approved a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD) in people ages 10 to 25 years. Sold as Penmenvy ...
My son, 25, was told to wait to see his GP for a headache – he’d been dead a week when ...
AT the age of 25, Alex Theodossiadis was finding his feet in the world as a DJ. But five years ago, Alex started experiencing ...
pulmonologyadvisor14 天
FDA Approves More Broadly Protective Meningococcal Vaccine
The vaccine is an injectable suspension for intramuscular use that combines components of GlaxoSmithKline's 2 well-established meningococcal vaccines, Bexsero and Menveo. HealthDay News — The U.S.
psychiatryadvisor.com16 天
FDA Approves More Broadly Protective Meningococcal Vaccine
Vaccine helps protect against the A, B, C, W, and Y serogroups of Neisseria meningitidis. (HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A ...
contemporarypediatrics20 天
Breaking down invasive meningococcal disease vaccines, including MenABCWY
Amin Barakat, MD, FAAP, details meningococcal disease vaccines and highlights the recently FDA-approved MenABCWY vaccine from GSK. Invasive meningococcal disease (IMD) is a life-threatening infection ...
healthday21 天
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...
BioPharma Dive22 天
GSK’s 5-in-1 meningococcal shot wins FDA approval
The Food and Drug Administration on Friday gave a green light to a new meningococcal vaccine from GSK. Dubbed Penmenvy, the “5-in-1” shot is approved for people aged 10 through 25 years old and ...
GSK gets meningitis vaccine green light from US FDA
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake of Donald Trump's election for a second term as President. The Food and ...
This is Money23 天
GSK gets meningitis vaccine green light from US FDA
It targets five major bacteria of Invasive Meningococcal Disease (IMD), a significant cause of meningitis and septicaemia. Up to one in six people who contract IMD die from the condition within 24 ...
Nasdaq23 天
FDA Approves GSK's Penmenvy, 5-in-1 Meningococcal Vaccine For MenABCWY Protection
(RTTNews) - GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
PMLiVE23 天
GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval
Invasive meningococcal disease (IMD) is an uncommon but serious illness caused by the bacterium Neisseria meningitidis. It is a major cause of meningitis and septicaemia, and can result in long-term ...